Increased risk of recurrence and disease-specific death following delayed postoperative radiation for Merkel cell carcinoma

被引:2
作者
Alexander, Nora A. [1 ,2 ]
Schaub, Stephanie K. [3 ,4 ,6 ]
Goff, Peter H. [1 ]
Hippe, Daniel S. [4 ]
Park, Song Y. [1 ]
Lachance, Kristina [1 ]
Bierma, Marika [1 ]
Liao, Jay J. [4 ]
Apisarnthanarax, Smith [4 ]
Bhatia, Shailender [3 ,5 ]
Tseng, Yolanda D. [3 ,4 ]
Nghiem, Paul T. [1 ]
Parvathaneni, Upendra [3 ,4 ]
机构
[1] Univ Washington, Dept Med, Seattle, WA USA
[2] Washington Univ, Sch Med, Dept Med, Div Dermatol, St Louis, MO USA
[3] Univ Washington, Dept Radiat Oncol, Seattle, WA USA
[4] Fred Hutchinson Canc Ctr, Clin Res Div, Seattle, WA USA
[5] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[6] Univ Washington, Sch Med, Dept Radiat Oncol, 1959 NE Pacific St Seattle, Seattle, WA 98195 USA
关键词
adjuvant; carcinoma; dermatologic surgical procedures; Merkel Cell; patient outcome; THERAPY; HEAD; RADIOTHERAPY; IRRADIATION; SURGERY; PATIENT; TIME;
D O I
10.1016/j.jaad.2023.07.1047
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Merkel cell carcinoma (MCC) is often treated with surgery and postoperative radiation therapy (PORT). The optimal time to initiate PORT (Time -to -PORT [ttPORT ]) is unknown. Purpose: We assessed if delays in ttPORT were associated with inferior outcomes. Methods: Competing risk regression was used to evaluate associations between ttPORT and locoregional recurrence (LRR) for patients with stage I/II MCC in a prospective registry and adjust for covariates. Distant metastasis and death were competing risks. Results: The cohort included 124 patients with median ttPORT of 41 days (range: 8-125 days). Median follow-up was 55 months. 17 (14%) patients experienced a LRR, 14 (82%) of which arose outside the radiation field. LRR at 5 years was increased for ttPORT [8 weeks vs # 8 weeks, 28.0% vs 9.2%, P = .006. There was an increase in the cumulative incidence of MCC-specific death with increasing ttPORT (HR = 1.14 per 1-week increase, P = .016). Limitations: The relatively low number of LRRs limited the extent of our multivariable analyses.
引用
收藏
页码:261 / 268
页数:8
相关论文
共 50 条
  • [21] Postoperative radiotherapy for patients with oral squamous cell carcinoma with intermediate risk of recurrence: A case match study
    Barry, Conor P.
    Wong, Daniel
    Clark, Jonathan R.
    Shaw, Richard J.
    Gupta, Ruta
    Magennis, Patrick
    Triantafyllou, Asterios
    Gao, Kan
    Brown, James S.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2017, 39 (07): : 1399 - 1404
  • [22] Risk Factors Associated With Reoperation and Disease-Specific Mortality in Patients With Medullary Thyroid Carcinoma
    Kuo, Eric J.
    Sho, Shonan
    Li, Ning
    Zanocco, Kyle A.
    Yeh, Michael W.
    Livhits, Masha J.
    JAMA SURGERY, 2018, 153 (01) : 52 - 59
  • [23] Recurrence and Survival in Patients With Merkel Cell Carcinoma Undergoing Surgery Without Adjuvant Radiation Therapy to the Primary Site
    Frohm, Marcus L.
    Griffith, Kent A.
    Harms, Kelly L.
    Hayman, James A.
    Fullen, Douglas R.
    Nelson, Christine C.
    Wong, Sandra L.
    Schwartz, Jennifer L.
    Bichakjian, Christopher K.
    JAMA DERMATOLOGY, 2016, 152 (09) : 1001 - 1007
  • [24] Positive impact of radiation dose on disease free survival and locoregional control in postoperative radiotherapy for squamous cell carcinoma of esophagus
    Moon, S.
    Kim, H.
    Chie, E.
    Kim, J.
    Park, C.
    DISEASES OF THE ESOPHAGUS, 2009, 22 (04): : 298 - 304
  • [25] Postoperative Radiation Therapy Is Indicated for "Low-Risk" Pathologic Stage I Merkel Cell Carcinoma of the Head and Neck Region but Not for Other Locations
    Bierma, Marika M.
    Goff, Peter H.
    Hippe, Daniel S.
    Lachance, Kristina
    Schaub, Stephanie K.
    Wallner, Kent
    Tseng, Yolanda D.
    Liao, Jay J.
    Apisarnthanarax, Smith
    Nghiem, Paul
    Parvathaneni, Upendra
    ADVANCES IN RADIATION ONCOLOGY, 2024, 9 (02)
  • [26] Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy
    Hosni, Ali
    Huang, Shao Hui
    Chiu, Kevin
    Xu, Wei
    Su, Jie
    Bayley, Andrew
    Bratman, Scott V.
    Cho, John
    Giuliani, Meredith
    Kim, John
    O'Sullivan, Brian
    Ringash, Jolie
    Waldron, John
    Spreafico, Anna
    Yu, Eugene
    de Almeida, John R.
    Monteiro, Eric
    Chepeha, Douglas B.
    Irish, Jonathan C.
    Goldstein, David P.
    Hope, Andrew
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 103 (02): : 363 - 373
  • [27] Model for End-Stage Liver Disease Correlates with Disease Relapse and Death of Patients with Merkel Cell Carcinoma
    Gambichler, Thilo
    Becker, Juergen C.
    Susok, Laura
    Kaepynen, Riina
    Abu Rached, Nessr
    CANCERS, 2023, 15 (12)
  • [28] Merkel Cell Polyomavirus Small T Antigen mRNA Level Is Increased following In Vivo UV-Radiation
    Mogha, Ariane
    Fautrel, Alain
    Mouchet, Nicolas
    Guo, Na
    Corre, Sebastien
    Adamski, Henri
    Watier, Eric
    Misery, Laurent
    Galibert, Marie-Dominique
    PLOS ONE, 2010, 5 (07):
  • [29] Delayed postoperative radiation therapy in local control of squamous cell carcinoma of the tongue and floor of the mouth
    Amar, Ali
    Chedid, Helma Maria
    Curioni, Otavio Alberto
    Dedivitis, Rogerio Aparecido
    Rapoport, Abrao
    Cernea, Claudio Roberto
    Brandao, Lenine Garcia
    EINSTEIN-SAO PAULO, 2014, 12 (04): : 477 - 479
  • [30] Perioperative Lymphopenia is Associated with Increased Risk of Recurrence and Worse Survival Following Hepatectomy for Hepatocellular Carcinoma
    Tsilimigras, Diamantis I.
    Endo, Yutaka
    Ratti, Francesca
    Marques, Hugo P.
    Cauchy, Francois
    Lam, Vincent
    Poultsides, George A.
    Popescu, Irinel
    Alexandrescu, Sorin
    Martel, Guillaume
    Kitago, Minoru
    Guglielmi, Alfredo
    Hugh, Tom
    Aldrighetti, Luca
    Gleisner, Ana
    Shen, Feng
    Endo, Itaru
    Pawlik, Timothy M.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (04) : 2568 - 2578